Antibody-Drug Conjugates and Ocular Toxicity
Journal of Ocular Pharmacology and Therapeutics · 01.12.2023 · 39 (10) · 675-691
DOI: 10.1089/jop.2023.0069 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, erschienen am 01.12.2023. Verfasst von Mustafa Jaffry und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, New Jersey, USA. Hauptthemen laut MEDLINE: Immunoconjugates, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 107 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
ORCID-Profile: Mustafa Jaffry, Hassaam Choudhry
Zitieren
APA
Jaffry, M., Choudhry, H., Aftab, O. M., & Dastjerdi, M. H. (2023). Antibody-Drug Conjugates and Ocular Toxicity. Journal of Ocular Pharmacology and Therapeutics, 39(10), 675-691. https://doi.org/10.1089/jop.2023.0069
Vancouver
Jaffry M, Choudhry H, Aftab OM, Dastjerdi MH. Antibody-Drug Conjugates and Ocular Toxicity. Journal of Ocular Pharmacology and Therapeutics. 2023;39(10):675-691. doi:10.1089/jop.2023.0069
BibTeX
@article{Jaffry2023,
author = {Jaffry, Mustafa and Choudhry, Hassaam and Aftab, Owais M and Dastjerdi, Mohammad H},
title = {Antibody-Drug Conjugates and Ocular Toxicity},
journal = {Journal of Ocular Pharmacology and Therapeutics},
year = {2023},
volume = {39},
number = {10},
pages = {675--691},
doi = {10.1089/jop.2023.0069}
}
EUVIMED